Umbralisib
id:
umbralisib-302-9961053
title:
Umbralisib
text:
Umbralisib, sold under the brand name Ukoniq, is an anti-cancer medication for the treatment of marginal zone lymphoma (MZL) and follicular lymphoma (FL). It is taken by mouth. Umbralisib is a kinase inhibitor including PI3K-delta and casein kinase CK1-epsilon. The most common side effects include increased creatinine, diarrhea-colitis, fatigue, nausea, neutropenia, transaminase elevation, musculoskeletal pain, anemia, thrombocytopenia, upper respiratory tract infection, vomiting, abdominal pain
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Umbralisib
date created:
date modified:
2024-01-30T15:40:16Z
main entity:
{"identifier":"Q27088612","url":"https://www.wikidata.org/entity/Q27088612"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/3/3c/Umbralisib.svg","width":600,"height":735}
fields total:
13
integrity:
15